Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

Efficacy of Remestemcel-L Treatment in Steroid Refractory Acute Graft-Versus-Host Disease in Children: An Aggregate Analysis

Joanne Kurtzberg, MD, Paul J Martin, MD, Susan Prockop, MD, Elizabeth Burke, ANP, Karen Segal, PhD

Blood (2020) 136 (Supplement 1): 12.

https://doi.org/10.1182/blood-2020-138593

Published: 2020

Journal Articles

Stat3 -/- Alloreactive Donor T Cells Reduce FAO but Increase Leakage of ROS in Response to PD-1 Signaling Triggered By Host-Tissue PD-L1, Leading to Prevention of Gvhd While Preserving GVL Effect

Xiaoqi Wang, MD, Shijie Yang, PhD, Yating Wang, PhD, Xiwei Wu, PhD, Martha Salas, Qingxiao Song, MD PhD, Hanjun Qin, Ubaydah Nasri, Arthur D. Riggs, PhD, Paul J Martin, MD, Xi Zhang, Defu Zeng, MD PhD

Blood (2019) 134 (Supplement_1): 198.

https://doi.org/10.1182/blood-2019-127228

Published: 2019

Journal Articles

Expansion of Th/Tc17 T Cells and Loss of CX3CR1 + Macrophages Play a Critical Role in the Pathogenesis of Steroid-Refractory Acute Intestinal Gvhd

Qingxiao Song, MD PhD, Xiaoning Wang, MD, Paul J Martin, MD, Yuanzhong Chen, MD PhD, Defu Zeng, MD PhD

Blood (2019) 134 (Supplement_1): 1925.

https://doi.org/10.1182/blood-2019-126261

Published: 2019

Journal Articles

Tissue-Resident PSGL1 lo CD4 + T Cells Interact with B Cells Via PD-1 and PD-L2 in Gvhd Target Tissues to Augment Autoimmune-like Chronic Gvhd

Xiaohui Kong, PhD, Deye Zeng, MD, Xiwei Wu, PhD, Shijie Yang, PhD, Bixin Wang, Qingxiao Song, MD PhD, Yongping Zhu, Martha Salas, Hanjun Qin, Ubaydah Nasri, Ryotaro Nakamura, MD, Paul J Martin, MD, Aimin Huang, Defu Zeng, MD PhD

Blood (2019) 134 (Supplement_1): 5607.

https://doi.org/10.1182/blood-2019-126315

Published: 2019

Journal Articles

Stat3 Regulates Alloreactive T Cell Susceptibility Towards PD-L1-Mediated Tolerance Signaling, Gvhd and GVL Activity

Shijie Yang, PhD, Xiaoqi Wang, MD, Yuankun Zhang, PhD, Deye Zeng, MD, Qingxiao Song, MD, Paul J Martin, MD, Xi Zhang, Defu Zeng, MD

Blood (2018) 132 (Supplement 1): 3323.

https://doi.org/10.1182/blood-2018-99-119474

Published: 2018

Journal Articles

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Qingxiao Song, MD, Xiaoning Wang, MD, Paul J Martin, MD, Yuanzhong Chen, MD PhD, Defu Zeng, MD

Blood (2018) 132 (Supplement 1): 2030.

https://doi.org/10.1182/blood-2018-99-119966

Published: 2018

Journal Articles

Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation

Kasey J Leger, MD MSc, K. Scott Baker, MD MS, Kara Cushing-Haugen, MS, Mary E. Flowers, MD, Wendy M. Leisenring, ScD, Paul J. Martin, MD, Jason A. Mendoza, MD MPH, Kerryn Reding, RN, PhD, Karen L. Syrjala, PhD, Stephanie J Lee, MD MPH, Eric J Chow, MD MPH

Blood (2017) 130 (Supplement 1): 3269.

https://doi.org/10.1182/blood.V130.Suppl_1.3269.3269

Published: 2017

Journal Articles

A Phase II Trial Evaluating the Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed By Autologous Transplantation, for High-Risk Relapsed or Refractory Non-Hodgkin's Lymphoma

Victor A. Chow, MD, Joseph Rajendren, MD, Andrew Shields, MD, Darrell R. Fisher, PhD, Frederick R. Appelbaum, MD, Ryan D. Cassaday, MD, Andrew J. Cowan, MD, Paul J. Martin, MD, Leona Holmberg, MD PhD, Ted Gooley, PhD, Philip A. Stevenson, MS, John M. Pagel, MD PhD, Damian J. Green, MD, Oliver W. Press, MD PhD, Ajay K. Gopal, MD

Blood (2017) 130 (Supplement 1): 2018.

https://doi.org/10.1182/blood.V130.Suppl_1.2018.2018

Published: 2017

Journal Articles

Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation

Giancarlo Fatobene, MD, Barry E. Storer, PhD, Rachel B. Salit, MD, Stephanie J. Lee, MD PhD, Paul J. Martin, MD, Guang-Shing Cheng, MD, Colleen Delaney, MD, Frederick R. Appelbaum, MD, Brenda M. Sandmaier, MD, Filippo Milano, MD PhD, Mary E. Flowers, MD

Blood (2017) 130 (Supplement 1): 73.

https://doi.org/10.1182/blood.V130.Suppl_1.73.73

Published: 2017

Journal Articles

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Blood (2016) 128 (22): 505.

https://doi.org/10.1182/blood.V128.22.505.505

Published: 2016

Journal Articles

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Brenda M Sandmaier, MD, David G Maloney, MD PhD, Barry E. Storer, PhD, Gitte Olesen, MD, Michael B. Maris, MD, Jonathan A Gutman, MD, Soren Lykke Petersen, MD DMSC, Amelia Langston, MD, Thomas Chauncey, Wolfgang Bethge, MD, Michael A Pulsipher, MD, Brian Thomas Kornblit, MD PhD, Ann E Woolfrey, MD, Marco Mielcarek, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD, Rainer F. Storb, MD

Blood (2016) 128 (22): 506.

https://doi.org/10.1182/blood.V128.22.506.506

Published: 2016

Journal Articles

Extrafollicular CD4 + T and B Interaction Induces Chronic Gvhd in the Absence of Germinal Center Formation

Ruishu Deng, MD PhD, Christian Hurtz, PhD, Chanyu Yue, PhD, Gang Xiao, PhD, Hua Yu, PhD, Markus Muschen, MDPhD, Stephen J. Forman, MD, Paul J. Martin, MD, Defu Zeng, MD

Blood (2015) 126 (23): 1875.

https://doi.org/10.1182/blood.V126.23.1875.1875

Published: 2015

Journal Articles

Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4 + T Cells Early after HCT

Xiong Ni, MD, Qingxiao Song, MD, Ruishu Deng, MD PhD, Hua Jin, BS, Kaniel M. Cassady, BS, Mingfeng Zhang, PhD, Stephen J. Forman, MD, Paul J. Martin, MD, Jianmin Wang, MD PhD, Defu Zeng, MD

Blood (2015) 126 (23): 1882.

https://doi.org/10.1182/blood.V126.23.1882.1882

Published: 2015

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

Journal Articles

Pre-Transplant Ferritin, Albumin and Platelet Count Add Prognostic Information to Comorbidities for Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes: A Multi-Center Discovery-Validation Study

Jennifer E. Vaughn, MD MSPH, Barry E. Storer, PhD, Philippe Armand, MD PhD, Roberto Raimondi, MD, Christopher J Gibson, MD, Alessandro Rambaldi, MD, Fabio Ciceri, MD, Rosi Oneto, MD, Benedetto Bruno, MD PhD, Paul J. Martin, MD, Brenda M. Sandmaier, MD, Rainer F. Storb, MD, Mohamed L. Sorror, MD MSc

Blood (2014) 124 (21): 421.

https://doi.org/10.1182/blood.V124.21.421.421

Published: 2014

Journal Articles

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Stephanie J. Lee, MD MPH, Paul A. Carpenter, MD, Edus Houston Warren, MD PhD, Michael Boeckh, MD, Barry E. Storer, PhD, David Levine, PhD, Wenhong Fan, Lue Ping Zhao, PhD, John A. Hansen, MD

Blood (2014) 124 (21): 665.

https://doi.org/10.1182/blood.V124.21.665.665

Published: 2014

Journal Articles

Major Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors

Eric J Chow, MD MPH, Kara Cushing-Haugen, MS, Wendy Leisenring, ScD, Michael Boeckh, MD, Guang-Shing Cheng, MD, Stephanie J. Lee, MD MPH, Paul J. Martin, MD, Beth Mueller, PhD, Stephen Schwartz, PhD, K. Scott Baker, MD MS

Blood (2014) 124 (21): 431.

https://doi.org/10.1182/blood.V124.21.431.431

Published: 2014

Journal Articles

Evaluation of Published Single-Nucleotide Polymorphisms (SNPs) Associated with Cytomegalovirus Infection and Disease after Hematopoietic Cell Transplantation in a Large Caucasian Cohort

Sachiko Seo, MD, Wenhong Fan, John A. Hansen, MD, Barry E. Storer, PhD, Steven A. Pergam, MDMPH, Margaret L. Green, MD, Sezen Ozkok, MD, Sonia Goyal, MD, Cynthia Fisher, MD, Sangeeta Hingorani, MD MPH, Edus H. Warren, MD PhD, Paul J. Martin, MD, Lue Ping Zhao, Michael Boeckh, MD

Blood (2014) 124 (21): 182.

https://doi.org/10.1182/blood.V124.21.182.182

Published: 2014

Journal Articles

Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

Marco Mielcarek, MD, Terrence Furlong, Paul V. O'Donnell, MD PhD, Barry E. Storer, PhD, Rainer F. Storb, MD, Paul A. Carpenter, MD, Paul J. Martin, MD

Blood (2014) 124 (21): 1161.

https://doi.org/10.1182/blood.V124.21.1161.1161

Published: 2014

Journal Articles

A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality

Margaret L. MacMillan, MD, Marie Robin, MD PhD, Andrew C Harris, MD, Todd E. Defor, MS, Paul J. Martin, MD, Amin Alousi, MD, Vincent T Ho, MD, Javier Bolanos-Meade, MD, James L.M. Ferrara, MD, D.Sc., Richard J. Jones, MD, Mukta Arora, MD MS, Bruce R. Blazar, MD, Shernan G. Holtan, MD, David Jacobsohn, MD, Marcelo C. Pasquini, MD MS, Gerard Socie, MD PhD, Joseph H. Antin, MD, John E. Levine, MD, M.S., Daniel J. Weisdorf, MD

Blood (2014) 124 (21): 188.

https://doi.org/10.1182/blood.V124.21.188.188

Published: 2014

NARROW

Efficacy of Remestemcel-L Treatment in Steroid Refractory Acute Graft-Versus-Host Disease in Children: An Aggregate Analysis

Stat3 -/- Alloreactive Donor T Cells Reduce FAO but Increase Leakage of ROS in Response to PD-1 Signaling Triggered By Host-Tissue PD-L1, Leading to Prevention of Gvhd While Preserving GVL Effect

Expansion of Th/Tc17 T Cells and Loss of CX3CR1 + Macrophages Play a Critical Role in the Pathogenesis of Steroid-Refractory Acute Intestinal Gvhd

Tissue-Resident PSGL1 lo CD4 + T Cells Interact with B Cells Via PD-1 and PD-L2 in Gvhd Target Tissues to Augment Autoimmune-like Chronic Gvhd

Stat3 Regulates Alloreactive T Cell Susceptibility Towards PD-L1-Mediated Tolerance Signaling, Gvhd and GVL Activity

Neutralizing IL-2 Early after HCT Specifically Prevents Expansion of Donor GM-CSF-Producing CD4 + T Cells That Initiate Acute Gut Gvhd

Lifestyle Factors and Subsequent Ischemic Heart Disease Risk after Hematopoietic Cell Transplantation

A Phase II Trial Evaluating the Efficacy of Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide Followed By Autologous Transplantation, for High-Risk Relapsed or Refractory Non-Hodgkin's Lymphoma

Comparison of Chronic Graft-Versus-Host Disease Severity and Functional Status after Cord Blood, Haploidentical Related and 1-Allele Mismatched Unrelated Donor Hematopoietic Cell Transplantation

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Extrafollicular CD4 + T and B Interaction Induces Chronic Gvhd in the Absence of Germinal Center Formation

Host Tissue PD-L1 Separates GVL Effect from Gvhd after Temporary Depletion of Donor CD4 + T Cells Early after HCT

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Pre-Transplant Ferritin, Albumin and Platelet Count Add Prognostic Information to Comorbidities for Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes: A Multi-Center Discovery-Validation Study

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Major Morbidity and Mortality Differences Between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors

Evaluation of Published Single-Nucleotide Polymorphisms (SNPs) Associated with Cytomegalovirus Infection and Disease after Hematopoietic Cell Transplantation in a Large Caucasian Cohort

Posttransplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

A Refined Clinical Risk Score at Onset of Treatment for Acute Gvhd That Predicts Response to Initial Therapy, Survival and Transplant-Related Mortality

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only